Hypoglycemia is the most common adverse reaction of insulin therapy, including Lantus, and may be life-threatening. Do not administer Lantus via an insulin pump or intravenously because severe hypoglycemia can occur. ![]() If mixed or diluted, the solution may become cloudy, and the onset of action/time to peak effect may be altered in an unpredictable manner. Advise patients to rotate injection site to unaffected areas and closely monitor for hypoglycemia.ĭo not dilute or mix Lantus with any other insulin or solution. Repeated insulin injections into areas of lipodystrophy or localized cutaneous amyloidosis may result in hyperglycemia sudden change in the injection site (to unaffected area) has been reported to result in hypoglycemia. Changes in insulin regimen including, strength, manufacturer, type, injection site or method of administration may result in the need for a change in insulin dose or an adjustment in concomitant drugs. Modify insulin regimen only under medical supervision. Monitor blood glucose in all patients treated with insulin. ![]() ![]() Insulin pens, needles, or syringes must never be shared between patients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |